🔗 Share this article

This year's Nobel Prize in medical science was awarded for transformative findings that illuminate how the body's defense network targets harmful pathogens while protecting the body's own cells.

Three esteemed scientists—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this honor.

Their research uncovered specialized "security guards" within the immune system that remove rogue defense cells capable of attacking the organism.

The discoveries are now paving the way for new treatments for immune disorders and malignancies.

These laureates will divide a prize fund worth 11 million SEK.

Decisive Discoveries

"Their research has been decisive for understanding how the body's defenses functions and the reason we don't all develop serious autoimmune diseases," stated the chair of the Nobel Committee.

This team's research explain a core question: How does the defense system protect us from numerous infections while leaving our healthy cells unharmed?

The body's protection system employs white blood cells that search for indicators of infection, even viruses and bacteria it has never encountered.

These defenders utilize detectors—known as receptors—that are generated by chance in a vast number of variations.

That gives the defense network the ability to combat a wide array of threats, but the randomness of the process inevitably creates immune cells that can attack the body.

Security Guards of the Immune System

Researchers earlier understood that some of these problematic defense cells were destroyed in the thymus—where white blood cells develop.

This year's award recognizes the identification of regulatory T-cells—described as the body's "peacekeepers"—which patrol the system to neutralize other immune cells that attack the body's own tissues.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, MS, and RA.

A Nobel panel stated, "The findings have laid the foundation for a new field of research and spurred the development of new therapies, for example for tumors and immune disorders."

In cancer, T-regs block the body from fighting the tumor, so research are focused on reducing their quantity.

For self-attack disorders, experiments are exploring increasing regulatory T-cells so the organism is no longer being harmed. A similar approach could also be effective in reducing the chances of organ transplant rejection.

Pioneering Studies

Professor Shimon Sakaguchi, from Osaka University, performed tests on rodents that had their immune gland extracted, leading to autoimmune disease.

The researcher showed that introducing defense cells from healthy animals could stop the illness—implying there was a system for blocking immune cells from attacking the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an genetic autoimmune disease in rodents and humans that resulted in the identification of a genetic factor critical for the way T-regs operate.

"The pioneering work has revealed how the immune system is controlled by T-reg cells, preventing it from accidentally targeting the healthy cells," commented a leading biological science expert.

"This work is a striking example of how basic physiological study can have far-reaching consequences for human health."